The results presented in this paper demonstrate for the first time that the gap junction protein, Cx43, when expressed in human metastatic lung carcinoma cells, suppresses several phenotypic characteristics of lung CSCs, including resistance to cisplatin, and reduces their abundance amongst the bulk cancer cell population. Here, GJA1 is linked to cancer.